Insights on the Global HIV Drugs Market to 2028 | Industry Statistics, Emerging Demands, Forecast to 2028
The global HIV drugs market is anticipated to grow at a CAGR of nearly 4.2% during the forecast period (2022-2028). Human immunodeficiency virus (HIV) is a chronic and life-threatening disease, which attacks immune cells known as CD-4 cells, making the body susceptible to infections and other diseases. HIV drugs are defined as the medicines that are to be taken for the prevention of the HIV. The drugs are highly effective for preventing HIV when taken as prescribed. The major driving factors contributing to the market growth include the rising prevalence and burden of HIV, growing investment in R&D related to these drugs coupled with the rise in the availability of novel drugs that poses better efficacy. For instance, as per the US Department of Health & Human Services, in 2018, there were nearly 37.9 million people globally living with HIV/AIDS. An estimated 1.7 million individuals globally became newly infected with HIV in 2018.These drugs are majorly available in a number of categories that broadly include integrase inhibitors, protease inhibitors, multi-class combination products, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) and others. Currently, pre-exposure prophylaxis drugs are considered to be the base of HIV/AIDS treatment, since there is no solid cure or a preventive vaccine available for HIV. Thus, the presence of huge patient pool demands the pre-exposure prophylaxis drugs for the treatment of HIV, which is projected to drive the growth of the market during the forecast period.
Some key players operating in the market include GlaxoSmithKline plc, Pfizer Inc., and Gilead Sciences, Inc., among others. Some new FDA approvals for HIV drugs has been witnessed. For instance, in July 2020, the US FDA approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies owing to resistance, intolerance or safety considerations.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global HIV Drugs Market at https://orionmarketreports.com/request-sample/?id=97178&submit=Request+Sample%0D%0A
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Medication Class
By Distribution Channel
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape: GlaxoSmithKline plc, Pfizer Inc., and Gilead Sciences, Inc., among others.
A full report is available at: https://orionmarketreports.com/global-hiv-drugs-market/97178/
Global HIV Drugs Market Report by Segment
By Application
Multi-Class Combination Drugs
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Protease Inhibitors (PIs)
Entry Inhibitors
HIV Integrase Stand Transfer Inhibitors
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights on the Global HIV Drugs Market to 2028 | Industry Statistics, Emerging Demands, Forecast to 2028 here
News-ID: 2599152 • Views: …
More Releases from Orion Market Research
US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecas …
The US geriatric medicine market is projected to grow at a CAGR of 4.6% during the forecast period. The US has high per capita income; access to advanced healthcare, a large elderly population, and a high prevalence of chronic diseases are some of the major factors driving the geriatric medicine market in the country.
Moreover, a significant presence of key market players, such as Pfizer Inc., Bristol-Myers Squibb Co., Abbott Laboratories…
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
The global urometer market is anticipated to grow at a considerable CAGR of 6.9% during the forecast period. The increasing cases of prostate cancer are expected to propel the growth of the global urometer market. Other than skin cancer, prostate cancer is the most common cancer in the US. According to the American Cancer Society (ACS), as of March 2022, around 268,490 new cases of prostate cancer and around…
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global urethral dilators market is anticipated to grow at a considerable CAGR of 4.9% during the forecast. The growing incidence of Healthcare-Acquired Infections (HAI) is Boosting the Global Urethral Dilators Market. These are infections that patients get while receiving treatment for medical or surgical conditions. These infections can be occurred in hospitals, surgical centers, ambulatory clinics, and long-term care facilities such as nursing homes and rehabilitation facilities.
To…
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
The global transvaginal endoscopy market is anticipated to grow at a significant CAGR of 7.3% during the forecast period. Some of the prominent factors driving the market growth during the forecast period include the rising incidence of infertility among the female rising incidence of infertility globally, coupled with the increasing use of minimally invasive surgery. The MIS procedures involves minminal use of surgical incisions, and with the advent of laproscopic…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…